Study of Roxadustat's Effect on Anemia in Patients With Diabetic Kidney Disease
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 124 participants.
Also called NCT07359027
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 124 participants
- Sponsor
- Registry
-
NCT07359027
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT07359027. Allocation not applicable; no masking; primary purpose treatment. Start 2021-11-02 (actual); primary completion 2022-12-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study of Roxadustat's Effect on Anemia in Patients With Diabetic Kidney Disease
- Condition
- Diabetic Kidney Disease
- Condition
- Anemia
- Intervention (Drug)
- Roxadustat
- Lead sponsor
- Second Xiangya Hospital of Central South University
- Collaborator
- Xiangya Hospital of Central South University
- Collaborator
- The Third Xiangya Hospital of Central South University
Record details
- Record id
cardio:ct-nct07359027- Content hash
624b1be1e6e13e7d1d862dc6dee5e00d8d70966abb64448d15191c217898579e